New Alzheimer's drug targets brain receptors to boost memory
NCT ID NCT06995573
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called NSC001 in 90 people with mild to moderate Alzheimer's disease. The drug is designed to activate a specific receptor in the brain (M1 muscarinic) that may help with memory and thinking. The main goal is to check if the drug is safe and tolerable, while also exploring if it improves cognitive function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NSC001
What this could lead to
If successful, this could point toward a new treatment to ease cognitive symptoms in Alzheimer's disease.
What could go wrong
This is an early phase 2a trial with only 90 participants, focused mainly on safety. It may not show clear cognitive benefits, and the drug could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic Altenburger Land GmbH
NOT_YET_RECRUITINGAltenburg, 04600, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dynamikos GmbH Institut fuer Studien zur Psychischen Gesundheit
RECRUITINGMannheim, 68165, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft GmbH
RECRUITINGSalzburg, State of Salzburg, 5020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University Innsbruck
RECRUITINGInnsbruck, 6020, Austria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University Vienna
RECRUITINGVienna, 1090, Austria
Contact
Contact Phone: •••-•••-••••
-
SANOS Clinic
RECRUITINGRatingen, 40882, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitaetsmedizin Goettingen
RECRUITINGGöttingen, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Clinic Köln
RECRUITINGCologne, 50937, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Graz
RECRUITINGGraz, Styria, 8036, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zentrum fuer klinische Forschung Dr. I. Schoell GmbH
RECRUITINGBad Homburg, 61348, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••